JENNIFER ZALAZNIK: Open Payments
NPI 1073945499 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $283 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $152 |
| Lilly USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Dynavax Technologies Corporation | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $22 |
Products named: VRAYLAR, JARDIANCE, MOUNJARO, SHINGRIX, Veozah, UBRELVY, REXULTI, Heplisav-B.
Industry payments across IA — which companies pay providers there.
